An interventional study of Repetitve transcranial magnetic stimulation and Sham transcranial magnetic stimulation in Stroke, Acute, Dysphagia and Pneumonia, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 49 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-10-03.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 41 studies in Stroke by Cairo University — 20 open to participants now, 22 under way, none of them phase 3. Stroke · Cairo University.
Among the 41 studies in Stroke by Cairo University, this one is the 3rd largest by planned enrollment of the 38 interventional ones that give a count, is one of 12 that started in 2025, is one of 38 with no phase, reaches primary completion later than 8 of the 21 other live ones, and was the 8th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →20 of the 41 studies in Stroke by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 40 wk–60 wk · Healthy volunteers
Cairo University · Sites in Egypt
Ages 50–65
Cairo University · Sites in Egypt
Ages 50–60
Cairo University · Sites in Egypt
Ages 40–55
Cairo University · Sites in Egypt
Ages 55–65
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 49 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
41 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 12 started in 2025.
This study's planned enrollment of 70 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 38 interventional studies, 68 across the 3 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Stroke by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520253Cairo UniversityEffect of Virtual Reality on Cortical Reorganization and Upper Extremity Functional Recovery in Patients With Subacute Stroke | 2026-11-30 |
| NCT07727902Cairo UniversityFunctional Inspiratory Muscle Training for Gait Recovery in Patients With Chronic Stroke | 2026-12-01 |
| NCT06302946Cairo UniversityEffect of Neuromuscular Stimulation and Mindfulness Exercise in Patients With Stroke | 2026-12-01 |
| NCT07626242Cairo UniversityEffect of Non-invasive Vagus Nerve Stimulation on Cerebrovascular Reactivity and Cognition in Chronic Stroke Patients | 2027-02-15 |
| NCT07947433Cairo UniversityEffect of taVNS on Post-stroke Dysphagia | 2027-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 41 studies in Stroke by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in improving post-stroke dysphagia and swallowing coordination after stimulation of the unaffected hemisphere, however it's efficacy on the prevalence of pneumonia has not yet been examined.
Purpose of the study: To determine the effect of adding low frequency repetitive transcranial magnetic stimulation to conventional oropharyngeal physical therapy program on the prevalence of aspiration pneumonia in in patients with post stroke dysphagia.
Seventy acute ischemic stroke patients with oropharyngeal dysphagia from both sexes will represent the sample of this study. They will be diagnosed by a neurologist and stroke diagnosis was confirmed by brain MRI and/or CT. They will be selected from the stroke unit El Kasr El Ainy hospital, Cairo university.
Patients will be randomly assigned into two equal groups, the control group (A) and the study group (B). Control group (GA) will be treated using a designed physical therapy intervention for oropharyngeal dysphagia consists of a selected physical therapy rehabilitation program for oropharyngeal muscles in addition to sham repetitive transcranial magnetic stimulation. Study group (GB) will receive low frequency (1 Hz) rTMS to the contra-lesional cerebral hemisphere in addition to the same Oropharyngeal physical therapy program for dysphagia as in group A.
Modified Mann Assessment of Swallowing Ability (MASA) will initially used to confirm dysphagia in acute stroke. The Gugging swallowing screening (GUSS) test will be used to detect aspiration risk. A2DS2 scale will be used to detect stroke associated pneumonia (SAP). Criteria of modified Center for Disease Control and Prevention (CDC) will be used to assess SAP via assessing 4 main measures (body temperature (BT), Total Leukocyte count (TLC), Arterial blood gases (ABG), and Respiratory Rate (RR) .
The whole Intervention will consist of 12 sessions, 3 days /week for 4 consecutive weeks , Total duration of the session (TMS + PT session) will be from 40min to 60 min.
Primary \& secondary outcomes will be assessed at the baseline and immediately after the completion of the whole treatment program.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group (A) will receive conventional oral care and oropharyngeal physical therapy program for dysphagia including; Exercise therapy for the oropharyngeal and tongue muscles , in addition to sham transcranial magnetic stimulation on the contralesional cerebral hemisphere.
Device: Sham transcranial magnetic stimulation
Group (B) will received low frequency (1 Hz) repetitive transcranial magnetic stimulation to the contralesional cerebral hemisphere in addition to the same Oropharyngeal physical therapy program for dysphagia as in group A.
Device: Repetitve transcranial magnetic stimulation
The Magstim Rapid2 magnetic stimulator system (Model P/N 3576-23-09, Magstim Company, Whitland, UK) was used to deliver rTMS electrical currents via a figure of 8 coil applied to the scalp against the targeted contralesional motor " Hot spot" , at a depth of approximately 1 cm . The inhibitory rTMS will be applied to the intact cerebral hemisphere at 1 Hz with a train of 1200 for 5 consecutive days.
Repetitive TMS via a sham Magstim coil (identical appearance and noise, but no active stimulation). Identical stimulation schedules as patients in study group.
The Gugging swallowing screen (GUSS)
It's a valid and a reliable bedside screening test to detect dysphagia and aspiration risk. The GUSS has 100% sensitivity. It begins with simple indirect swallow screen then if the total score is reached a direct swallowing test is done. It's composed of three parts: semisolid swallowing trial, liquid swallowing trial and solid swallowing trial. GUSS total score is 20. The score of the preliminary or the direct test is five. If the total score is reached the direct test can be done. Each subitem in the direct test has a score of five points. Each item of them requires the previous item to be completed.
Time frame: Baseline and immediately after the intervention.
(A2DS2) scale to detect risk of pneumonia
A2DS2 scale is used to detect stroke associated pneumonia (SAP). Consists of five items of scale which are: age, atrial fibrillation, dysphagia, sex and stroke severity. Total score of A2DS2 is 10. A2DS2 scoring tool: age more than 75 years=1, atrial fibrillation=1, dysphagia=2, male sex=1; stroke severity: is detected by NIHSS score. If NIHSS score is from 0-4=0, 5-15=3, and more than16=5. Patients with score of 6 or more are at high risk of pneumonia.
Time frame: Baseline and immediately after the intervention.
Microbiological Examination of the sputum
Sputum specimens collected on sterile sputum containers by patient self-expectoration or aspiration should be checked for quality in a bacteriology laboratory. Quality check typically includes calculating the number of leukocytes (WBC) and buccal squamous epithelial (BSE) cells in the 100× view field .
Time frame: Baseline and immediately after the intervention
Body Temperature
According to the diagnostic criteria of stroke associated pneumonia (SAP): follow the modified Center for Disease Control and Prevention (CDC), All patients that were suspected to had pneumonia and their vitals followed the criteria of the CDC . Body temperature was one of the vitals that confirm pneumonia, Fever (\>38°C) with no other recognized cause is one of the diagnostic criteria for pneumonia.
Time frame: Baseline and immediately after the intervention.
Total Leukocyte Count (TLC)
According to the diagnostic criteria of SAP follow the modified Center for Disease Control and Prevention (CDC), All patients that were suspected to had pneumonia and their vitals followed the criteria of the CDC. Leukopenia (\<4000 WBC/mm3) or leukocytosis (\>12 000 WBC/mm3). A blood sample is taken from the patient to assess the total leukocyte count.
Time frame: Baseline and immediately after the intervention.
Arterial Blood Gas (ABG) Test to assess Oxygen Saturation (OS)
According to the diagnostic criteria of SAP follow the modified Center for Disease Control and Prevention (CDC), All patients that were suspected to had pneumonia and their vitals followed the criteria of the CDC. TLC to assess worsening gas exchange (e.g., O2 desaturation \[e.g., PaO2/FiO2≤240\], increased oxygen requirements\*) by taking a blood sample from the patient.
Time frame: Baseline and immediately after the intervention.
Respiratory Rate (RR)
Fast breathing was found to be the most useful sign predicting Stroke associated pneumonia (SAP) for both male and female patients .
Time frame: Baseline and immediately after the intervention.
Mann Assessment of Swallowing Ability (MASA)
Screening tool for identifying eating and swallowing disorders in acute stroke , used to quantify aspiration risk via bedside test * predicting dysphagia and aspiration in stroke * 24 clinical items * General patient examination (alertness, cooperation, auditory comprehension, aphasia, apraxia, and dysarthria) * 5-point to 10-point rating scale * Total score: 200 points * cut off is 177 points * Risk of Dysphagia: No abnormality (≥178), mild dysphagia (168-177), moderate dysphagia (139-167), severe dysphagia (≤138) * Risk of Aspiration: no abnormality (≥170), mild (149-169), moderate (141-148), severe (≤140).
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for Dec 2025, 9 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 9 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.